Public trial registry of the CCC-Munich

Trial AIO-HEP-0116 NALIRICC

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
AIO-HEP-0116 NALIRICC
World
Full title
:

A randomized phase II trial of nal-IRI and 5-Fluorouracil compared to 5-Fluorouracil in patients with cholangio- and gallbladder carcinoma previously treated with gemcitabine-based therapies

World
Responsible organization
:
2. Med 2. Med Ismaninger Str. 22 81675 München Germany
Indications
Classification Code Description
- Gallbladder carcinoma
- Livertumor
Trial design
World
Phase
:
II
Status
World
Status
:
Recruitment finished
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy
:

Chemo - Therapieart: palliativ

Participants
Function Prename Surname Organization
World Responsible contact Hana Algül 2. Med 2. Med Ismaninger Str. 22 81675 München Germany Magnifier